1. Home
  2. MMLP vs NBP Comparison

MMLP vs NBP Comparison

Compare MMLP & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Martin Midstream Partners L.P. Limited Partnership

MMLP

Martin Midstream Partners L.P. Limited Partnership

SELL

Current Price

$1.72

Market Cap

90.0M

Sector

Energy

ML Signal

SELL

NBP

NovaBridge Biosciences American Depositary Shares

SELL

Current Price

$0.83

Market Cap

96.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MMLP
NBP
Founded
2002
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
96.0M
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
MMLP
NBP
Price
$1.72
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.67
AVG Volume (30 Days)
22.0K
★ 526.3K
Earning Date
10-21-2026
08-20-2026
Dividend Yield
★ 1.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
★ $1,653,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
★ 0.65
N/A
52 Week Low
$1.76
$0.75
52 Week High
$3.24
$5.19

Technical Indicators

Market Signals
Indicator
MMLP
NBP
Relative Strength Index (RSI) 40.13 30.80
Support Level N/A N/A
Resistance Level $2.38 $1.45
Average True Range (ATR) 0.22 0.07
MACD -0.01 0.01
Stochastic Oscillator 8.04 31.05

Price Performance

Historical Comparison
MMLP
NBP

About MMLP Martin Midstream Partners L.P. Limited Partnership

Martin Midstream Partners LP has a diverse set of operations focused on the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products, including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing, and distribution; and natural gas liquids marketing, distribution and transportation services. The company operates in four segment Terminalling and storage, Transportation, Sulfur service, and Specialty products segment. The majority of the revenue is derived from the Specialty products segment.

About NBP NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Share on Social Networks: